Professionals 445 results
Capabilities 58 results
Practice Area
Practice Area
eDiscovery & Information Governance
Practice Area
Government Program Fraud, False Claims Act & Qui Tam Litigation
Experience 34 results
Experience
|April 30, 2025
Experience
|April 30, 2025
Rapid Ruling: Fifth Circuit Affirms Winston Win on Summary Judgment the Day After Oral Argument
Experience
|May 10, 2024
Insights & News 921 results
Benefits Blast
|November 20, 2025
|10+ Min Read
2026 Proxy Season: A Look Ahead to Executive Compensation Issues and Considerations
As the 2026 proxy season approaches, companies should be mindful of developments in required executive compensation disclosures and related issues that may arise as they prepare proxy statements. This alert surveys key developments and provides specific action items for companies to consider.
Winston’s Environmental Law Update
|November 19, 2025
|4 Min Read
Companies Need to Know These Key Exemptions in EPA’s Proposed Revision to the PFAS Reporting Rule
On November 10, 2025, the Environmental Protection Agency (EPA or the Agency) issued a proposed rule to revise the reporting and recordkeeping requirements for per- and polyfluoroalkyl substances (PFAS) under Section 8(a)(7) of the Toxic Substances Control Act (TSCA).
False Claims Act Playbook
|October 30, 2025
|5 Min Read
On October 15, 2025, the United States District Court for the District of Nebraska (the Court) dismissed Pharos Capital Group and its related investment funds (Pharos Capital) from a qui tam or whistleblower suit brought under the antiretaliation provision of the False Claims Act (31 U.S.C. § 3730(h)) (the FCA), against Pharos Capital and Charter Health Care Group (Charter), a portfolio company of Pharos Capital.
Other Results 28 results
Site Content
Site Content
Location


